BlackRock’s Tevogen Inc TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,395
Closed -$110K 5910
2026
Q1
$110K Buy
24,395
+501
+2% +$6.14K ﹤0.01% 4939
2025
Q4
$396K Sell
23,894
-7,149
-23% -$186K ﹤0.01% 4542
2025
Q3
$1.22M Buy
31,043
+1,640
+6% +$80.7K ﹤0.01% 4236
2025
Q2
$1.84M Buy
29,403
+12,716
+76% +$724K ﹤0.01% 4078
2025
Q1
$901K Buy
16,687
+4,650
+39% +$306K ﹤0.01% 4225
2024
Q4
$620K Buy
12,037
+7,419
+161% +$483K ﹤0.01% 4355
2024
Q3
$85.1K Buy
4,618
+361
+8% +$10.6K ﹤0.01% 4703
2024
Q2
$154K Buy
+4,257
New +$277K ﹤0.01% 4597

Other funds holding TVGN

BlackRock's TVGN Position: Q2 2026 in Review

BlackRock sold out of Tevogen Inc (TVGN) in Q2 2026, closing a stake of 24,395 shares — an estimated $110K sold.

BlackRock first reported a position in TVGN in Q2 2024 and held it in 8 quarters. The position peaked at $1.84M in Q2 2025. 31 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

  • BlackRock reported no remaining Tevogen Inc position as of Q2 2026 after selling out during the quarter.
  • BlackRock sold 24,395 Tevogen Inc shares in Q2 2026, an estimated $110K.
  • BlackRock first reported a position in Tevogen Inc in Q2 2024 and held it in 8 quarters.
  • BlackRock's Tevogen Inc position peaked at $1.84M in Q2 2025.
  • 31 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.